Form 8-K - Current report:
SEC Accession No. 0001615774-19-005452
Filing Date
2019-04-08
Accepted
2019-04-08 16:39:11
Documents
1
Period of Report
2019-04-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K s117292_8k.htm 8-K 30749
  Complete submission text file 0001615774-19-005452.txt   31966
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 19737764
SIC: 8731 Services-Commercial Physical & Biological Research